Fundraising FoxViridian Therapeutics
Waltham, US · Founded 2020 · Delaware corporation · 3 known investors
Find your way into Viridian Therapeutics
Sign up to see every warm intro you have to Viridian Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Viridian Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Viridian Therapeutics develops treatments for thyroid eye disease, a rare autoimmune condition affecting the eyes and orbit. The company focuses on clinical development and patient support programs in the biotech sector.
Founders & leadership
Viridian Therapeutics was founded in 2020 by Jonathan Violin.
Board
Investors · 3
How we know: Longitude Capital's portfolio page · the VCSheet dataset · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$29M disclosed across 2 rounds · 2020
▶$27MraisedSep 2020 · 9 investors · BiotechnologyRule 506(b)
- Jonathan ViolinExecutive Officer, Director
- Tomas KiselakDirector
- Peter HarwinDirector
- Offering amount
- $27M
- Amount sold
- $27M
- First sale
- Sep 2020
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$2MraisedMay 2020 · 2 investors · BiotechnologyRule 506(b)
- Jonathan ViolinExecutive Officer, Director
- Peter HarwinDirector
- Tomas KiselakDirector
- Offering amount
- $5M
- Amount sold
- $2M
- First sale
- Apr 2020
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 1
Companies working in the same space as Viridian Therapeutics.
Frequently asked questions
- What does Viridian Therapeutics do?
- Viridian Therapeutics develops treatments for thyroid eye disease, a rare autoimmune condition affecting the eyes and orbit. The company focuses on clinical development and patient support programs in the biotech sector.
- Who founded Viridian Therapeutics?
- Viridian Therapeutics was founded by Jonathan Violin in 2020.
- Who are Viridian Therapeutics's investors?
- Viridian Therapeutics's investors include Broadview Ventures, Longitude Capital, MRL Ventures Fund.
- How much funding has Viridian Therapeutics raised?
- Viridian Therapeutics has disclosed $29M raised across 2 rounds.
- Where is Viridian Therapeutics headquartered?
- Viridian Therapeutics is headquartered in Waltham, US.